Korean Translations

Neurology® 2015; Vol. 85

Neurology® 2014; Vol. 83

Changing outcome in inflammatory neuropathies: Rasch–comparative responsiveness, Draak et al. 83(23):2124-2132.

Results of 2-year vitamin B treatment on cognitive performance: Secondary data from an RCT, van der Zwaluw et al. 83(23):2153-2157.

Explanatory factors for the increased mortality of stroke patients with depression, Ayerbe et al. 83(22):2007-2012.

Connective tissue anomalies in patients with spontaneous cervical artery dissection, Giossi et al. 83(22):2032-2037.

Epilepsy-related clinical characteristics and mortality: A systematic review and meta-analysis, Nevalainen et al. 83(21):1968-1977.

Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States, Duffy et al. 83(20):1823-1830.

Physical activity attenuates age-related biomarker alterations in preclinical AD, Okonkwo et al. 83(19):1753-1760.

Agreement between TOAST and CCS ischemic stroke classification: The NINDS SiGN Study, McArdle et al. 83(18):1653-1660.

Levetiracetam reduces abnormal network activations in temporal lobe epilepsy, Wandschneider et al. 83(17):1508-1512.

Midlife personality and risk of Alzheimer disease and distress: A 38-year follow-up, Johannson et al. 83(17):1538-1544.

Parkinson disease and smoking revisited: Ease of quitting is an early sign of the disease, Ritz et al. 83(16):1396-1402.

Evidence-based guideline summary: Diagnosis and treatment of limb-girdle and distal dystrophies: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine, Narayanaswami et al. 83(16):1453-1463.

Association of cerebral microbleeds with mortality in stroke patients having atrial fibrillation, Song et al. 83(15):1308-1315.

Opioids for chronic noncancer pain: A position paper of the American Academy of Neurology, Franklin. 83(14):1277-1284.

Neurology® 2014; Vol. 82

Joint effect of mid- and late-life blood pressure on the brain: The AGES-Reykjavik Study, Muller et al. 82(24):2187-2195.

Anti-agrin autoantibodies in myasthenia gravis, Gasperi et al. 82(22):1976-1983.

Peripheral hypoxia in restless legs syndrome (Willis-Ekbom disease), Salminen et al. 82(21):1856-1861.

Reconciling the clinical practice guidelines on Bell palsy from the AAO-HNSF and the AAN, Schwartz et al. 82(21):1927-1929.

Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease, Hong et al. 82(18):1597-1604.

Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy, Westwood et al. 82(18):1613-1619.

Autoimmune thyroiditis as a risk factor for stroke: A historical cohort study, Karch and Thomas. 82(18):1643-1652.

Seoul criteria for PiB(−) subcortical vascular dementia based on clinical and MRI variables, Kim et al. 82(17):1529-1535.

Reduction in perceived stress as a migraine trigger: Testing the “let-down headache” hypothesis, Lipton et al. 82(16):1395-1401.

Migraine trait symptoms in migraine with and without aura, Jürgens et al. 82(16):1416-1424.

Prevalence of idiopathic normal-pressure hydrocephalus, Jaraj et al. 82(16):1449-1454.

Restless legs syndrome status as a predictor for lower physical function, Zhang et al. 82(14):1212-1218.

tDCS in patients with disorders of consciousness: Sham-controlled randomized double-blind study, Thibaut et al. 82(13):1112-1118.

Rolandic epilepsy has little effect on adult life 30 years later: A population-based study, Camfield and Camfield. 82(13):1162-1166.

Poststroke atrial fibrillation: Cause or consequence?: Critical review of current views, Sposato et al. 82(13):1180-1186.

Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE Study, Poli et al. 82(12):1020-1026.

Lower stroke risk with lower blood pressure in hemodynamic cerebral ischemia, Powers et al. 82(12):1027-1032.

Chronic kidney disease is associated with dementia independent of cerebral small-vessel disease, Miwa et al. 82(12):1051-1057.

Comorbidity and medication in REM sleep behavior disorder: A multicenter case-control study, Frauscher et al. 82(12):1076-1079.

PRECREST: A phase II prevention and biomarker trial of creatine in at-risk Huntington disease, Rosas et al. 82(10):850-857.

Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON) trial: Main results, Marshall et al. 82(9):744-751.

Influence of seizures on stroke outcomes: A large multicenter study, Huang et al. 82(9):768-776.

Homocysteine and progression of generalized small-vessel disease: The SMART-MR Study, Kloppenberg et al. 82(9):777-783.

Ketogenic diet for adults in super-refractory status epilepticus, Thakur et al. 82(8):665-670.

Summary of evidence-based guideline update: Prevention of stroke in nonvalvular atrial fibrillation: Report of the Guideline Development Subcommittee of the American Academy of Neurology, Culebras et al. 82(8):716-724.

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders, Sato et al. 82(6):474-481.

Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal, Roberts et al. 82(4):317-325.

Herpes zoster as a risk factor for stroke and TIA: A retrospective cohort study in the UK, Breuer et al. 82(3):206-212.

Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women, Bove et al. 82(3):222-229.

Tongue pressure as a novel biomarker of spinal and bulbar muscular atrophy, Mano et al. 82(3):255-262.

Neurology® 2013; Vol. 81

Is IVIg therapy warranted in progressive lower motor neuron syndromes without conduction block?, Simon NG, Aver G, Lomen-Hoerth C, et al. 81(24):2116-2120.

B-type natriuretic peptides and mortaility after stroke: A systematic review and meta-analysis, García-Berrocoso T, Giralt D, Bustamante A, et al. 81(23):1976-1985.

Temporal trends in new exposure to antiepileptic drug monotherapy and suicide-related behavior, Pugh MJ, Hesdorffer D, Wang CP, et al. 81(22):1900-1906.

Cerebral microbleeds are related to loss of white matter structural integrity, Akoudad S, de Groot M, Koudstaal PJ, et al. 81(22):1930-1937.

Residual fatigue in Guillain-Barré syndrome is related to axonal loss, Drenthen J, Jacobs BC, Maathuis EM, et al. 81(21):1827-1831.

Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity, Jack CR, Wiste HJ, Weigand SD, et al. 81(20):1732-1740.

Fatigue in the acute phase after first stroke predicts poorer physical health 18 months later, Lerdal A and Gay CL. 81(18):1581-1587.

Evidence-based guideline update: Vagus nerve stimulation for the treatment of epilepsy: Report of the Guideline Development Subcommittee of the American Academy of Neurology, Morris GL, Gloss D, Buchhalter J, et al. 81(16):1453-1459.

Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease: A meta-analysis, Ji Y, Tan S, Xu Y, et al. 81(15):1298-1307.

Migraine and white matter hyperintensities: The ARIC MRI study, Hamedani AG, Rose KM, Peterlin BL, et al. 81(15):1308-1313.

Incidence and prevalence of small-fiber neuropathy: A survey in the Netherlands, Peters MJH, Bakkers M, Merkie ISJ, et al. 81(15):1356-1360.

Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine, Cernuda-Morollón E, Larrosa D, Ramón C, et al. 81(14):1191-1196.

Migraine and structural changes in the brain: A systematic review and meta-analysis, Bashir A, Lipton RB, Ashina S, et al. 81(14):1260-1268.

Migraine prevalence, socioeconomic status, and social causation, Stewart et al. 81(11):948-955.

Relations of arterial stiffness and endothelial function to brain aging in the community, Tsao et al. 81(11):984-991.

MRI-identified pathology in adults with new-onset seizures, Hakami et al. 81(10):920-927.

Comparison of the response to endovascular reperfusion in relation to site of arterial occlusion, Lemmens et al. 81(7):614-618.

Principal component analysis of PiB distribution in Parkinson and Alzheimer diseases, Campbell et al. 81(6):520-527.

Inverse occurrence of cancer and Alzheimer disease: A population-based incidence study, Musicco et al. 81(4):322-328.

Mitochondrial encephalomyopathies—Fifty years on: The Robert Wartenberg Lecture, DiMauro 81(3):281-291.

APOE genotype and MRI markers of cerebrovascular disease: Systematic review and meta-analysis, Schilling et al. 81(3):292-300.

MRI and MRS predictors of mild cognitive impairment in a population-based sample, Kantarci et al. 81(2):126-133.

Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2, Lam et al. 81(2):157-164.

Traumatic brain injury may be an independent risk factor for stroke, Burke et al. 81(1):33-39.

Prospective study of restless legs syndrome and mortality among men, Li et al. 81(1):52-59.

Neurology® 2013; Vol. 80

Family history of idiopathic REM behavior disorder: A multicenter case-control study, Dauvilliers et al. 80(24):2233-2235.

Severe carotid stenosis and impaired cerebral hemodynamics can influence cognitive deterioration, Balestrini et al. 80(23):2145-2150.

Thalamic glutamate/glutamine in restless legs syndrome: Increased and related to disturbed sleep, Allen et al. 80(22):2028-2034.

Summary of evidence-based guideline: Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: Report of the Guideline Development Subcommittee of the American Academy of Neurology, Armstrong et al. 80(22):2065-2069.

Syncope and orthostatic intolerance increase risk of brain lesions in migraineurs and controls, Kruit et al. 80(21):1958-1965.

Newly diagnosed atrial fibrillation linked to wake-up stroke and TIA: Hypothetical implications, Riccio et al. 80(20):1834-1840.

Effect of 4-aminopyridine on vision in multiple sclerosis patients with optic, Horton et al. 80(20):1862-1866.

Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later, Roe et al. 80(19):1784-1791.

Mortality in Guillain-Barré syndrome, van den Berg et al. 80(18):1650-1654.

Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke, Cotter et al. 80(17):1546-1550.

Pregnancy outcomes following gabapentin use: Results of a prospective comparative cohort study, Fujii et al. 80(17):1565-1570.

Interarm blood pressure difference and mortality in patients with acute ischemic stroke, Kim et al. 80(16):1457-1464.

Supplementary motor area stimulation for Parkinson disease: A randomized controlled study, Shirota et al. 80(15):1400-1405.

Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination, Szakács et al. 80(14):1315-1321.

CHADS2, CHA2DS2-VASc, and long-term stroke outcome in patients without atrial fibrillation, Ntaios et al. 80(11):1009-1017.

Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease, Prestia et al. 80(11):1048-1056.

Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy, DeGiorgio et al. 80(9):786-791.

Migraine prevention with a supraorbital transcutaneous stimulator: A randomized controlled trial, Schoenen et al. 80(8):697-704.

A randomized controlled trial of intranasal ketamine in migraine with prolonged aura, Afridi et al. 80(7):642-647.

A randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury, Cardenas et al. 80(6):533-539.

Depression in epilepsy: A systematic review and meta-analysis, Fiest et al. 80(6):590-599.

Predictors of recovery of responsiveness in prolonged anoxic vegetative state, Estraneo et al. 80(5):464-470.

Levetiracetam in pregnancy: Results from the UK and Ireland epilepsy and pregnancy registers, Mawhinney et al. 80(4):400-405.

Fatigue and fatigability in neurologic illnesses: Proposal for a unified taxonomy, Kluger et al. 80(4):409-416.

The spectrum of nonmotor symptoms in early Parkinson disease, Khoo et al. 80(3):276-281.

Complete stable remission and autoantibody specificity in myasthenia gravis, Baggi et al. 80(2):188-195.

Neurology® 2012; Vol. 79

Orexin receptor antagonism for treatment of insomnia: A randomized clinical trial of suvorexant, Herring et al. 79(23):2265-2274.

Dexamethasone and long-term survival in bacterial meningitis, Fritz et al. 79(22):2177-2179.

Evidence-based guideline update: Steroids and antivirals for Bell palsy: Report of the Guideline Development Subcommittee of the American Academy of Neurology, Gronseth and Paduga 79(22):2209-2213.

Migraine headache is present in the aura phase: A prospective study, Hansen et al. 79(20):2044-2049.

Dysfunction of the neuromuscular junction in spinal muscular atrophy types 2 and 3, Wadman et al. 79(20):2050-2055.

Parkinson disease and driving: An evidence-based review, Crizzle et al. 79(20):2067-2074.

Hormone therapy and Alzheimer disease dementia: New findings from the Cache County Study, Shao et al. 79(18):1846-1852.

Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis, Meng et al. 79(18):1853-1861.

Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization, Manjunath et al. 79(18):1908-1916.

Serum tight-junction proteins predict hemorrhagic transformation in ischemic stroke patients, Kazmierski et al. 79(16):1677-1685.

Serum lycopene decreases the risk of stroke in men: A population-based follow-up study, Karppi et al. 79(15):1540-1547.

Reversion from mild cognitive impairment to normal or near-normal cognition: Risk factors and prognosis, Koepsell and Monsell 79(15):1591-1598.

Past exposure to neuroleptic drugs and risk of Parkinson disease in an elderly cohort, Foubert-Samier et al. 79(15):1615-1621.

Poststroke fatigue following minor infarcts: A prospective study, Radman et al. 79(14):1422-1427.

Chocolate consumption and risk of stroke: A prospective cohort of men and meta-analysis, Larson et al. 79(12):1223-1229.

Lipid profiles and outcome in patients treated by intravenous thrombolysis for cerebral ischemia, Nardi et al. 79(11):1101-1108.

Chronic pain as a manifestation of potassium channel-complex autoimmunity, Klein et al. 79(11):1136-1144.

New ischemic lesions coexisting with acute intracerebral hemorrhage, Kang et al. 79(9):848-855.

Feasibility of antiepileptic drug withdrawal following extratemporal resective epilepsy surgery, Menon et al. 79(8):770-776.

Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis, Sinnecker et al. 79(7):708-714.

Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease: Report of the Guideline Development Subcommittee of the American Academy of Neurology, Armstrong and Miyasaki 79(6):597-603.

Environmental risk factors for REM sleep behavior disorder: A multicenter case-control study, Postuma et al. 79(5):428-434.

Comorbidity of migraine in children presenting with epilepsy to a tertiary care center, Kelley et al. 79(5):468-473.

Endothelial progenitor cells: A new key for endothelial dysfunction in migraine, Rodríquez-Osorio et al. 79(5):474-479.

Hematoma growth and outcomes in intracerebral hemorrhage: The INTERACT1 study, Delcourt et al. 79(4):314-319.

Assessing the efficacy of 2 screening measures for depression in people with epilepsy, Gandy et al. 79(4):371-375.

Subtherapeutic warfarin therapy entails an increased bleeding risk after stroke thrombolysis, Ruecker et al. 79(1):31-38.

Randomized trial of deep brain stimulation for Parkinson disease: Thirty-six-month outcomes, Weaver et al. 79(1):55-65.

Neurology® 2012; Vol. 78

Proteinuria and clinical outcomes after ischemic stroke, Kumai et al. 78(24):1909-1915.

Comparative safety of antiepileptic drugs during pregnancy, Hernández-Díaz et al. 78(21):1692-1699.

Patterns of treatment response in newly diagnosed epilepsy, Brodie et al. 78(20):1548-1554.

Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study, Schrijvers et al. 78(19):1456-1463.

Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society, Holland et al. 78(17):1346-1353.

A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease, Richard et al. 78(16):1229-1236.

Poststroke depression and emotional incontinence: Factors related to acute and subacute stages, Choi-Kown et al. 78(15):1130-1137.

Habitual intake of dietary flavonoids and risk of Parkinson disease, Gao et al. 78(15):1138-1145.

Long-term risk of developing epilepsy after febrile seizures: A prospective cohort study, Neligan et al. 78(15):1166-1170.

Predicting outcome after acute basilar artery occlusion based on admission characteristics, Greving et al. 78(14):1058-1063.

Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment, Eftimov et al. 78(14):1079-1084.

Neurobehavioral dysfunction in ALS has a negative effect on outcome and use of PEG and NIV, Chiò et al. 78(14):1085-1089.

Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine, Silberstein 78(13):976-984.

Evidence-based guideline: Intravenous immunoglobulin in the treatment of neuromuscular disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Patwa et al. 78(13):1009-1015.

Lamotrigine and aseptic meningitis, Simms et al. 78(12):921-927.

SMN1 gene duplications are associated with sporadic ALS, Blauw et al. 78(11):776-780.

Epileptic seizures at initial presentation in patients with brain arteriovenous malformation, Garcin et al. 78(9):626-631.

Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease, Watabe-Rudolph et al. 78(8)569-577.

Multimodal endovascular reperfusion therapies: Adjunctive antithrombotic agents in acute stroke, Lazzaro and Zaidat 78(7):501-506.

Pattern of brain tissue loss associated with freezing of gait in Parkinson disease, Kostić et al. 78(6):409-416.

Predicting outcome of IV thrombolysis–treated ischemic stroke patients: The DRAGON score, Strbian et al. 78(6):427-432.

APOE modifies the association between Aβ load and cognition in cognitively normal older adults, Kantarci et al. 78(4):232-240.

Randomized clinical trial for apogeotropic horizontal canal benign paroxysmal positional vertigo, Kim et al. 78(3):159-166.

Long-lasting treatment effect of rituximab in MuSK myasthenia, Díaz-Manera et al. 78(3):189-193.

Shared loci for migraine and epilepsy on chromosomes 14q12-q23 and 12q24.2-q24.3, Polvi et al. 78(3):202-209.

Nicotine treatment of mild cognitive impairment: A 6-month double-blind pilot clinical trial, Newhouse et al. 78(2):91-101.

Recovery after spinal cord infarcts: Long-term outcome in 115 patients, Robertson et al. 78(2):114-121.

Theta-burst stimulation of the left hemisphere accelerates recovery of hemispatial neglect, Koch et al. 78(1):24-30.

Neurology® 2008; Vol. 71

Stiff-person syndrome with amphiphysin antibodies: Distinctive features of a rare disease, Murinson and Guarnaccia 71(24):1955-1958.

Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease, Duara et al. 71(24):1986-1992.

High plasma glutamate concentrations are associated with infarct growth in acute ischemic stroke, Castellanos et al. 71(23):1862-1868.

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial, Sorenson et al. 71(22):1770-1775.

Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy, Borroni et al. 71(22):1796-1803.

Excessive acute migraine medication use and migraine progression, Bigal and Lipton 71(22):1821-1828.

Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome, Kuwabara et al. 71(21):1691-1695.

SEEG-guided thermocoagulations: A palliative treatment of nonoperable partial epilepsies, Catenoix et al. 71(21):1719-1726.

Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures, Faught et al. 71(20):1586-1593.

Cross-sensitivity of skin rashes with antiepileptic drug use, Hirsch et al. 71(19):1527-1534.

Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: A multicenter study, Saqqur et al. 71(17):1304-1312.

Improvements in memory function following anterior temporal lobe resection for epilepsy, Baxendale et al. 71(17):1319-1325.

Treatment of ocular symptoms in myasthenia gravis, Bhanushali at al. 71(17):1335-1341.

Main menu

User menu

Search

Korean Translations

Articles

About

Submit

Subscribers